Astera Labs (NASDAQ:ALAB) Stock Price Down 7.9% – Here’s Why

Shares of Astera Labs, Inc. (NASDAQ:ALAB) dropped 7.9% during trading on Tuesday . The stock traded as low as $251.17 and last traded at $260.23. 4,710,154 shares were traded during trading, a decline of 15% from the average session volume of 5,533,342 shares. The stock had previously closed at $282.52.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Roth Capital reiterated a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Barclays increased their price target on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Stifel Nicolaus upped their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $282.00.

Astera Labs Trading Up 20.0%

The company has a market capitalization of $51.37 billion, a PE ratio of 202.49, a PEG ratio of 3.01 and a beta of 3.66. The business has a fifty day moving average of $359.85 and a 200 day moving average of $228.24.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Activity

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the sale, the director directly owned 57,466 shares in the company, valued at $25,859,700. This represents a 5.75% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,676,845 shares of company stock worth $444,928,806 over the last 90 days. Company insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Reflection Asset Management purchased a new stake in Astera Labs during the 4th quarter worth about $25,000. CX Institutional boosted its stake in shares of Astera Labs by 1,330.8% in the 2nd quarter. CX Institutional now owns 186 shares of the company’s stock valued at $90,000 after buying an additional 173 shares during the period. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in shares of Astera Labs during the fourth quarter worth about $33,000. Finally, Wexford Capital LP acquired a new position in shares of Astera Labs during the third quarter worth about $39,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.